Invesco Biotechnology & Genome ETF Rating → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PBE Stock Alerts $63.58 -0.49 (-0.76%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy2.69Holdings in PBE have an aggregate rating of Moderate Buy based on 342 analyst ratings issued in the past year covering 29 companies (97.2% of the portfolio).PBE Aggregate Price Target$84.5633.00% UpsideHigh Prediction$111.18Average Prediction$84.56Low Prediction$60.20Holdings in PBE have an aggregate price target of $84.56 and a range of $60.20 to $111.18 covering 29 companies (97.2% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 PBE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.55%NBIXNeurocrine Biosciences$136.70-2.1%5 of 5 stars2.74$147.88 8.2%235.08%AMGNAmgen$310.15-0.9%5 of 5 stars2.52$305.65 -1.5%21Analyst Forecast5.05%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast5.03%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News4.95%BMRNBioMarin Pharmaceutical$81.03-0.8%5 of 5 stars2.63$107.50 32.7%19Short Interest ↑4.93%BIIBBiogen$221.50-0.6%5 of 5 stars2.65$288.46 30.2%26Positive News4.84%GILDGilead Sciences$65.96+2.1%5 of 5 stars2.39$83.69 26.9%18Analyst Revision4.76%TECHBio-Techne$80.91+1.7%4 of 5 stars2.82$80.50 -0.5%11Positive News3.38%MNKDMannKind$4.32+0.2%2 of 5 stars3.00$8.00 85.2%3Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.32%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑3.26%COLLCollegium Pharmaceutical$31.50-16.8%3 of 5 stars2.20$39.00 23.8%5Analyst DowngradeNews CoverageGap DownHigh Trading Volume3.21%UTHRUnited Therapeutics$264.27-0.7%5 of 5 stars2.90$308.78 16.8%10Insider Selling3.11%HALOHalozyme Therapeutics$43.15-1.6%5 of 5 stars2.83$53.14 23.2%6Analyst Forecast3.10%CPRXCatalyst Pharmaceuticals$15.94+1.9%5 of 5 stars3.00$26.71 67.6%5Analyst ForecastShort Interest ↑News Coverage3.06%TGTXTG Therapeutics$16.62-1.8%4 of 5 stars2.83$29.83 79.5%6Negative NewsGap Up2.90%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑Analyst Revision2.86%PTCTPTC Therapeutics$32.25+3.9%2 of 5 stars1.92$33.67 4.4%132.85%ITCIIntra-Cellular Therapies$64.96-0.9%5 of 5 stars2.90$90.17 38.8%10Earnings ReportAnalyst ForecastAnalyst Revision2.75%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Gap Down2.74%CLDXCelldex Therapeutics$39.92-2.8%1 of 5 stars2.80$66.00 65.3%5Analyst ForecastAnalyst RevisionNews Coverage2.68%VCELVericel$48.10-1.1%1 of 5 stars3.00$46.80 -2.7%6Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.65%DVAXDynavax Technologies$10.73-2.5%4 of 5 stars2.75$25.33 136.1%4Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage2.42%RGENRepligen$166.81+1.2%4 of 5 stars2.89$197.75 18.5%92.41%XENEXenon Pharmaceuticals$40.54-4.6%3 of 5 stars3.00$59.11 45.8%9Earnings ReportAnalyst ForecastNews CoverageGap Down2.27%VCYTVeracyte$21.37+3.6%3 of 5 stars2.60$27.50 28.7%5Earnings ReportAnalyst ForecastShort Interest ↑2.23%MYGNMyriad Genetics$25.47+0.9%2 of 5 stars2.50$24.86 -2.4%8Earnings ReportAnalyst UpgradeNews Coverage2.16%FOLDAmicus Therapeutics$9.23-2.6%5 of 5 stars2.83$18.40 99.3%6Earnings ReportAnalyst ForecastShort Interest ↓News CoverageGap Up1.91%ACADACADIA Pharmaceuticals$15.25+0.3%4 of 5 stars2.75$28.94 89.8%16Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.70%EYPTEyePoint Pharmaceuticals$12.09-4.6%2 of 5 stars3.00$34.14 182.4%7Analyst ForecastInsider BuyingAnalyst RevisionNews Coverage This page (NYSEARCA:PBE) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
